Biodesy™ Delta System Named Top New Biomedical Instrument at Photonics West 2016

SOUTH SAN FRANCISCO, Calif. – Feb 22, 2016 – Biodesy, Inc., a next-generation protein analysis company, today announced that the Biodesy™ Delta System has won the 2016 Prism Award in the category of Biomedical Instrumentation. The Prism Awards are a leading international competition that honors the best new optic and photonic products.

The Biodesy Delta System is the first and only product to enable researchers to distinguish functionally and clinically relevant protein changes in real time and high throughput. Based on optical measurement of signal from second harmonic generation (SHG), this revolutionary technology platform has the potential to accelerate drug discovery and transform our understanding of how proteins function.

“The 2016 Prism Award for Biomedical Instrumentation is a strong validation of our disruptive technology and our team’s dedication to innovation in protein analysis,” said Greg Yap, CEO of Biodesy. “We would like to thank SPIE, Photonics Media, and the judges for recognizing the Delta System’s unique ability to detect and characterize conformational change in proteins and other biological molecules and its potential to provide significant insights into treating human disease.” 

The Prism Awards (www.prismawards.org) are held in conjunction with SPIE Photonics West, the annual conference of the international society for optics and photonics. Applications are judged by a panel of leading industry experts. The finalists and winners that are ultimately chosen reflect the diversity of the program and celebrate innovations in the industry that have great promise to impact some of the biggest societal challenges.

About Biodesy

Biodesy is developing the first products and systems to rapidly and inexpensively measure both protein structure and function in real time, with applications including drug discovery, structural biology, and clinical biomarkers. Biodesy has developed a unique and highly sensitive technology for detecting conformational change in proteins and other biological molecules. Its technology, based on a phenomenon called second-harmonic generation (SHG), can monitor structural changes at any site within a protein, in real time. Since protein function is determined by its structure, and changes in structure cause changes in function, characterizing these changes will provide significant insights into human disease and how to treat it. Biodesy is located in South San Francisco, California. For more information, please visit www.biodesy.com.

The Biodesy Delta System is for Research Use Only and not for use in diagnostic procedures. Biodesy and the Biodesy logo are trademarks of Biodesy, Inc. All other brands may be trademarks of their respective holders.